LCEFX | RMEBX | LCEFX / RMEBX | |
Total Expense Ratio | 0.47 | 1.07 | 44% |
Annual Report Gross Expense Ratio | 0.47 | 1.07 | 44% |
Fund Existence | 13 years | 11 years | - |
Gain YTD | 11.799 | 13.527 | 87% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 250 | 400,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 10.6B | 111B | 10% |
Annual Yield % from dividends | 1.53 | 1.05 | 145% |
Returns for 1 year | -0.30 | 4.81 | -6% |
Returns for 3 years | 14.95 | 38.19 | 39% |
Returns for 5 years | 16.52 | 55.95 | 30% |
Returns for 10 years | 26.82 | 89.36 | 30% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
PJP | 94.07 | 0.64 | +0.68% |
Invesco Pharmaceuticals ETF | |||
AAPR | 27.92 | 0.03 | +0.12% |
Innovator Eq Dfnd Prot ETF 2 YrToApl2026 | |||
MHNC | 17.52 | -0.01 | -0.06% |
MAIDEN HOLDINGS NORTH AMERICA Ltd | |||
NBET | 31.45 | -0.05 | -0.16% |
Neuberger Berman Engy Trnstn & InfrasETF | |||
HQH | 18.97 | -0.06 | -0.32% |
abrdn Healthcare Investors |